Business Description
OSE Immunotherapeutics SA
ISIN : FR0012127173
Total Employee Number:
68Compare
Compare
Traded in other countries / regions
OSE.France6OP.GermanyORPOF.USA0RAD.UK IPO Date
2015-09-02Description
OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.64 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 1.27 | |||||
Debt-to-EBITDA | -1.13 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -1.01 | |||||
Beneish M-Score | -7.05 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -50.8 | |||||
3-Year EBITDA Growth Rate | -25.7 | |||||
3-Year EPS without NRI Growth Rate | -18.1 | |||||
3-Year FCF Growth Rate | -15.3 | |||||
3-Year Book Growth Rate | -11.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 211.31 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.28 | |||||
Quick Ratio | 1.28 | |||||
Cash Ratio | 0.91 | |||||
Days Sales Outstanding | 403.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.7 | |||||
Shareholder Yield % | 9.65 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -1396.26 | |||||
Net Margin % | -1439.06 | |||||
EBITDA Margin % | -1196.83 | |||||
FCF Margin % | -1301.94 | |||||
OCF Margin % | -1298.19 | |||||
ROE % | -79.53 | |||||
ROA % | -36.83 | |||||
ROIC % | -54.61 | |||||
3-Year ROIIC % | -1380.28 | |||||
ROC (Joel Greenblatt) % | -899.92 | |||||
ROCE % | -42.81 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 105.48 | |||||
PS Ratio | 29.59 | |||||
PB Ratio | 2.82 | |||||
EV-to-EBIT | -2.74 | |||||
EV-to-EBITDA | -3.02 | |||||
EV-to-Forward-EBITDA | -3.56 | |||||
EV-to-Revenue | 36.17 | |||||
EV-to-Forward-Revenue | 33.89 | |||||
EV-to-FCF | -2.78 | |||||
Price-to-GF-Value | 1.32 | |||||
Earnings Yield (Greenblatt) % | -36.5 | |||||
FCF Yield % | -41.62 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ORPOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OSE Immunotherapeutics SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 3.044 | ||
| EPS (TTM) ($) | -1.991 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.55 | ||
| 3-Year Sortino Ratio | 59.99 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.145295 | ||
| 20-Day SMA ($) | 5.147 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 4.43 - 11.6 | ||
| Shares Outstanding (Mil) | 23.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OSE Immunotherapeutics SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OSE Immunotherapeutics SA Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
OSE Immunotherapeutics SA Frequently Asked Questions
What is OSE Immunotherapeutics SA(ORPOF)'s stock price today?
The current price of ORPOF is $4.43. The 52 week high of ORPOF is $11.60 and 52 week low is $4.43.
When is next earnings date of OSE Immunotherapeutics SA(ORPOF)?
The next earnings date of OSE Immunotherapeutics SA(ORPOF) is .
Does OSE Immunotherapeutics SA(ORPOF) pay dividends? If so, how much?
OSE Immunotherapeutics SA(ORPOF) does not pay dividend.
Guru Commentaries on OTCPK:ORPOF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on OSE Immunotherapeutics SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers